What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
John N. Eble mostly deals with Pathology, Carcinoma, Renal cell carcinoma, Immunohistochemistry and Kidney.
He has researched Pathology in several fields, including Fluorescence in situ hybridization, Prostate and Mucinous tubular and spindle cell carcinoma.
His Carcinoma research incorporates themes from Grading, Cancer and Psammoma body.
John N. Eble studied Renal cell carcinoma and Cell that intersect with Progressive disease, Chromosomal translocation, Metastasis, TFE3 and Stage.
His study in Immunohistochemistry is interdisciplinary in nature, drawing from both Germ cell tumors, Seminoma, Intratubular germ cell neoplasia, Staining and Hyaline.
His biological study spans a wide range of topics, including Lymphangioleiomyomatosis, Tuberous sclerosis, Lymphangiomyoma and Epithelioid cell.
His most cited work include:
- The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
- The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder (1309 citations)
- The Heidelberg classification of renal cell tumours (1157 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pathology, Carcinoma, Renal cell carcinoma, Immunohistochemistry and Kidney.
His Pathology research is multidisciplinary, incorporating perspectives in Fluorescence in situ hybridization and Urinary bladder.
His studies examine the connections between Urinary bladder and genetics, as well as such issues in Adenocarcinoma, with regards to Prostate cancer.
The study incorporates disciplines such as Renal neoplasm, Prostatectomy, Psammoma body and Mucinous tubular and spindle cell carcinoma in addition to Carcinoma.
The concepts of his Renal cell carcinoma study are interwoven with issues in Cell, SDHB and TFE3.
The various areas that John N. Eble examines in his Immunohistochemistry study include Staining, Tuberous sclerosis, Stromal cell and Prostate.
He most often published in these fields:
- Pathology (79.75%)
- Carcinoma (19.41%)
- Renal cell carcinoma (18.57%)
What were the highlights of his more recent work (between 2016-2021)?
- Pathology (79.75%)
- Renal cell carcinoma (18.57%)
- Immunohistochemistry (16.46%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Pathology, Renal cell carcinoma, Immunohistochemistry, Clear cell and Fluorescence in situ hybridization.
His studies in Pathology integrate themes in fields like Renal neoplasm and Gene rearrangement.
John N. Eble has included themes like Genetics, Kidney, Immunostaining and TFE3 in his Renal cell carcinoma study.
His work in Immunohistochemistry addresses subjects such as SDHB, which are connected to disciplines such as Stroma and Tuberous sclerosis.
His Fluorescence in situ hybridization research includes themes of Bladder cancer and Cancer.
His Carcinoma research is multidisciplinary, relying on both Basal and Psammoma body.
Between 2016 and 2021, his most popular works were:
- Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists (43 citations)
- Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation (21 citations)
- Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study. (19 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
John N. Eble mainly investigates Pathology, Renal cell carcinoma, Immunohistochemistry, Carcinoma and Clear cell.
His Pathology research integrates issues from Renal neoplasm and SDHB.
His SDHB research incorporates elements of Stroma, PAX8, Immunostaining, Psammoma body and Fluorescence in situ hybridization.
His Carcinoma study combines topics from a wide range of disciplines, such as Gene rearrangement and Cytokeratin.
His work deals with themes such as Cell, Tuberous sclerosis and Biomarker, which intersect with Clear cell papillary renal cell carcinoma.
John N. Eble combines subjects such as Stage, Pathological, Chromophobe cell and Lymph node with his study of Differential diagnosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
